在与喘相关的气道上皮细胞中,对阿尔布罗尔治疗的表观基因组反应
Javier Perez-Garcia1, Maria Pino-Yanes2,3,4, Elizabeth G Plender5
1Genomics and Health Group, Department of Biochemistry, Microbiology, Cell Biology, and Genetics, Universidad de La Laguna (ULL), La Laguna, Tenerife, Canary Islands, Spain. jpegarci@ull.edu.es.
Clinical epigenetics
|October 2, 2023
概括
阿尔布醇是一种常见的喘药物,诱导了气道上皮细胞中的DNA甲基化变化. 这些表观遗传修饰可能会影响喘相关途径和支气管扩展剂药物反应.
科学领域:
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 肺部病理学 肺部病理学
- 药物基因组学 药物基因组学
背景情况:
- 阿尔布醇是喘的主要治疗方法.
- DNA甲基化 (DNAm) 在喘和支气管扩展剂药物反应 (BDR) 中起作用.
- 之前的研究并没有调查阿尔布特罗尔对气道上皮质DNA甲基化的影响.
研究的目的:
- 为了表征阿尔布特罗尔诱导的DNAm在呼吸道上皮细胞的变化.
- 评估这些表观遗传变化的功能后果.
- 探索遗传变异和临床因素对阿尔布特罗尔表观遗传效应的影响.
主要方法:
- 使用配对呼吸道上皮细胞培养的发现和验证研究设计.
- 儿童鼻上皮细胞的全表观基因组关联研究 (EWAS).
- 在独立的鼻腔和支气管上皮细胞样本中进行验证.
- 在基因变异和基因表达的分析.
- 基因组丰富分析.基因组丰富分析.
主要成果:
- 阿尔布特罗尔治疗主要诱导全基因组的低甲基化.
- 在CREB3L1,MYLK4-LINC01600和KSR1.1.中验证的DNAm变化.
- 遗传变异影响了DNAm的变化,影响了附近的基因表达 (例如,KSR1,LINC01600).
- 特定CpG的低甲基化与增加的基因表达相关.
- 表观遗传学效应独立于喘状况,但名义上与BDR相关.
- 在喘相关途径 (例如,IL-2,TNF-α,NF-κB信号传递) 中涉及的阿尔布托罗尔诱导的表观基因组修饰.
结论:
- 阿尔布特罗尔诱导呼吸道上皮质的表观遗传修饰.
- 这些表观基因组变化可能对喘管理具有临床意义.
- 这些发现突出了阿尔布特罗尔的作用机制和喘病理生理学之间的潜在联系.
关键词:
气道细胞 气道细胞这种药物是Albuterol.这就是CREB3L1的意思.通过DNA甲基化.欧洲经济联盟 (EWAS) 的成员.表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.在KSR1中,KSR1是KSR1.这就是MYLK4的原因.波多黎各人是一个波多黎各人.这是一种β2-激动剂.更多相关视频
08:42Isolating Bronchial Epithelial Cells from Resected Lung Tissue for Biobanking and Establishing Well-Differentiated Air-Liquid Interface Cultures
Published on: May 26, 2023
3.0K
14:48Flow Cytometric Isolation of Primary Murine Type II Alveolar Epithelial Cells for Functional and Molecular Studies
Published on: December 26, 2012
26.5K
相关概念视频
01:20Asthma: Pathogenesis and Management
433
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
433
01:26Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
290
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
290
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
326
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
326
01:19Antiasthma Drugs: Leukotriene Modifiers
338
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
338
01:29Asthma-I: Introduction
2.7K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.7K